Annual report pursuant to Section 13 and 15(d)

RESTATED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.24.3
RESTATED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Pre-funded warrants
Common Stock
Pre-funded warrants
Preferred Stock
Series E-2 Preferred Stock
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Series D Preferred stock
Series E-2 Preferred Stock
Total
Balance beginning at Dec. 31, 2021         $ 61 $ 157,260,859 $ (128,197,789)     $ 29,063,131
Balance beginning (in shares) at Dec. 31, 2021         6,110,125          
Balance beginning Series D preferred stock at Dec. 31, 2021               $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2021               111.11    
Stock-based compensation (Note7)           303,805       303,805
Retired shares (in shares)         (1)          
Net loss             (6,239,797)     (6,239,797)
Balance ending Series D preferred stock at Mar. 31, 2022               $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Mar. 31, 2022               111.11    
Balance ending at Mar. 31, 2022         $ 61 157,564,664 (134,437,586)     23,127,139
Balance ending (in shares) at Mar. 31, 2022         6,110,124          
Balance beginning at Dec. 31, 2021         $ 61 157,260,859 (128,197,789)     29,063,131
Balance beginning (in shares) at Dec. 31, 2021         6,110,125          
Balance beginning Series D preferred stock at Dec. 31, 2021               $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2021               111.11    
Net loss                   (11,874,840)
Balance ending Series D preferred stock at Jun. 30, 2022               $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Jun. 30, 2022               111.11    
Balance ending at Jun. 30, 2022         $ 61 157,984,617 (140,072,629)     17,912,049
Balance ending (in shares) at Jun. 30, 2022         6,110,122          
Balance beginning at Dec. 31, 2021         $ 61 157,260,859 (128,197,789)     29,063,131
Balance beginning (in shares) at Dec. 31, 2021         6,110,125          
Balance beginning Series D preferred stock at Dec. 31, 2021               $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2021               111.11    
Net loss                   (19,386,162)
Balance ending Series D preferred stock at Sep. 30, 2022               $ 1,382,023   1,382,023
Balance ending Series D preferred stock (in shares) at Sep. 30, 2022               111.11    
Balance ending at Sep. 30, 2022         $ 61 158,352,376 (147,583,951)     10,768,486
Balance ending (in shares) at Sep. 30, 2022         6,110,118          
Balance beginning at Dec. 31, 2021         $ 61 157,260,859 (128,197,789)     29,063,131
Balance beginning (in shares) at Dec. 31, 2021         6,110,125          
Balance beginning Series D preferred stock at Dec. 31, 2021               $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2021               111.11    
Stock-based compensation (Note7)           1,452,964       $ 1,452,964
Stock awards (Note 7) (in shares)                   440,250
Retired shares (in shares)         6          
Net loss             (31,792,618)     $ (31,792,618)
Issuance of common stock and pre-funded warrants, net of issuance costs         $ 33 9,429,734       9,429,767
Issuance of common stock and pre-funded warrants, net of issuance costs (in shares)         3,275,153          
Balance ending Series D preferred stock at Dec. 31, 2022               $ 1,382,023   1,382,023
Balance ending Series D preferred stock (in shares) at Dec. 31, 2022               111.11    
Balance ending at Dec. 31, 2022         $ 94 168,143,557 (159,990,407)     8,153,244
Balance ending (in shares) at Dec. 31, 2022         9,385,272          
Balance beginning at Mar. 31, 2022         $ 61 157,564,664 (134,437,586)     23,127,139
Balance beginning (in shares) at Mar. 31, 2022         6,110,124          
Balance beginning Series D preferred stock at Mar. 31, 2022               $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Mar. 31, 2022               111.11    
Stock-based compensation (Note7)           419,953       419,953
Retired shares (in shares)         (2)          
Net loss             (5,635,043)     (5,635,043)
Balance ending Series D preferred stock at Jun. 30, 2022               $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Jun. 30, 2022               111.11    
Balance ending at Jun. 30, 2022         $ 61 157,984,617 (140,072,629)     17,912,049
Balance ending (in shares) at Jun. 30, 2022         6,110,122          
Stock-based compensation (Note7)           367,759       367,759
Retired shares (in shares)         (4)          
Net loss             (7,511,322)     (7,511,322)
Balance ending Series D preferred stock at Sep. 30, 2022               $ 1,382,023   1,382,023
Balance ending Series D preferred stock (in shares) at Sep. 30, 2022               111.11    
Balance ending at Sep. 30, 2022         $ 61 158,352,376 (147,583,951)     10,768,486
Balance ending (in shares) at Sep. 30, 2022         6,110,118          
Balance beginning at Dec. 31, 2022         $ 94 168,143,557 (159,990,407)     8,153,244
Balance beginning (in shares) at Dec. 31, 2022         9,385,272          
Balance beginning Series D preferred stock at Dec. 31, 2022               $ 1,382,023   1,382,023
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2022               111.11    
Stock-based compensation (Note7)           408,206       408,206
Net loss             (7,190,470)     (7,190,470)
Conversion of warrants into common shares $ 3 $ 3                
Conversion of warrants into common shares (in shares) 355,235                  
Balance ending at Mar. 31, 2023         $ 97 168,551,763 (167,180,877)     1,370,983
Balance ending (in shares) at Mar. 31, 2023         9,740,507          
Balance beginning at Dec. 31, 2022         $ 94 168,143,557 (159,990,407)     8,153,244
Balance beginning (in shares) at Dec. 31, 2022         9,385,272          
Balance beginning Series D preferred stock at Dec. 31, 2022               $ 1,382,023   1,382,023
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2022               111.11    
Net loss                   (17,369,110)
Balance ending at Jun. 30, 2023         $ 97 168,971,520 (177,359,517)     (8,387,900)
Balance ending (in shares) at Jun. 30, 2023         9,740,507          
Balance beginning at Dec. 31, 2022         $ 94 168,143,557 (159,990,407)     8,153,244
Balance beginning (in shares) at Dec. 31, 2022         9,385,272          
Balance beginning Series D preferred stock at Dec. 31, 2022               $ 1,382,023   1,382,023
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2022               111.11    
Net loss                   (34,889,488)
Balance ending Series D preferred stock at Sep. 30, 2023                   19,202,023
Balance ending Series D preferred stock (in shares) at Sep. 30, 2023               111.11    
Balance ending at Sep. 30, 2023         $ 99 166,879,534 (194,879,895)     (28,000,262)
Balance ending (in shares) at Sep. 30, 2023         9,918,384          
Balance beginning at Dec. 31, 2022         $ 94 168,143,557 (159,990,407)     8,153,244
Balance beginning (in shares) at Dec. 31, 2022         9,385,272          
Balance beginning Series D preferred stock at Dec. 31, 2022               $ 1,382,023   1,382,023
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2022               111.11    
Stock-based compensation (Note7)           2,410,288       2,410,288
Exercise of warrants into common shares         $ 12 2,467,210       2,467,222
Exercise of warrants into common shares (in shares)         1,197,622          
Conversion of preferred stock to common stock       $ (13,142,368) $ 99 13,142,269        
Conversion of preferred stock to common stock (in shares)       (905.24) 9,947,684          
Reclassification of pre-funded warrants to liability           (3,239,112)       $ (3,239,112)
Shares issued     1,225.00              
Aggregate value of shares issued     $ 17,820,000           $ 17,820,000  
Stock awards (Note 7)         $ 2 (2)        
Stock awards (Note 7) (in shares)         213,532         1,617,000
Net loss             (42,770,610)     $ (42,770,610)
Issuance of common stock and pre-funded warrants, net of issuance costs (in shares)     1,225.00              
Balance ending Series D preferred stock at Dec. 31, 2023               $ 1,382,023   $ 1,382,023
Balance ending Series D preferred stock (in shares) at Dec. 31, 2023               111.11   111.11
Balance ending at Dec. 31, 2023       $ 4,677,632 $ 207 182,924,210 (202,761,017)     $ (15,158,968)
Balance ending (in shares) at Dec. 31, 2023       319.76 20,744,110          
Balance beginning at Mar. 31, 2023         $ 97 168,551,763 (167,180,877)     1,370,983
Balance beginning (in shares) at Mar. 31, 2023         9,740,507          
Stock-based compensation (Note7)           419,757       419,757
Net loss             (10,178,640)     (10,178,640)
Balance ending at Jun. 30, 2023         $ 97 168,971,520 (177,359,517)     (8,387,900)
Balance ending (in shares) at Jun. 30, 2023         9,740,507          
Stock-based compensation (Note7)           $ 497,878       497,878
Exercise of warrants into common shares         $ 2         649,250
Exercise of warrants into common shares (in shares)         177,877 649,248        
Reclassification of pre-funded warrants to liability           $ (3,239,112)       (3,239,112)
Net loss             (17,520,378)     (17,520,378)
Balance ending Series D preferred stock at Sep. 30, 2023                   19,202,023
Balance ending Series D preferred stock (in shares) at Sep. 30, 2023               111.11    
Balance ending at Sep. 30, 2023         $ 99 $ 166,879,534 $ (194,879,895)     $ (28,000,262)
Balance ending (in shares) at Sep. 30, 2023         9,918,384